[{"data":1,"prerenderedAt":25},["ShallowReactive",2],{"$f8O6we62n2zHgqkAmeW0Yq44Sd2A73UN7kBEFv0N4WTo":3},{"card":4,"examId":6,"chapterTitle":22,"prev":23,"next":24},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":14,"explanation":15,"explanationDetail":16,"mistakeHint":16,"lectureRef":16,"storyRef":16,"chapterSlug":17,"sectionCode":18,"sectionTitle":19,"clusterSlug":20,"term":16,"sequenceOrder":16,"regionWeight":16,"revisionMark":16,"isActive":21},"ch1-023","touhan","ヒトを対象とした臨床試験の実施基準はどれか。",0,[10,11,12,13],"GCP（Good Clinical Practice）","GPSP（Good Post-marketing Study Practice）","GLP（Good Laboratory Practice）","GVP（Good Vigilance Practice）","four","ヒトを対象とした臨床試験の基準は「GCP」です。Clinical（臨床の）の「C」と覚えるとアルファベットを見分けやすくなります。",null,"chapter-1","1-I-2","医薬品のリスク評価","risk-hyouka",true,"第1章 医薬品に共通する特性と基本的な知識","ch1-022","ch1-024",1784619073794]